Managing Chromoblastomycosis
Overview
Authors
Affiliations
Chromoblastomycosis is a subcutaneous fungal infection caused by the traumatic inoculation of the skin with pigmented saprophytic moulds. Although infection is rarely fatal, it is characteristically chronic and can be complicated by lymphatic damage and malignant transformation. Despite a variety of treatment modalities, which are often combined and include long courses of antifungals, surgical excision and destructive physical therapies, it remains one of the most difficult deep mycotic infections to eradicate.
Liu H, Sun J, Li M, Cai W, Chen Y, Liu Y Front Cell Infect Microbiol. 2022; 12:810604.
PMID: 35252030 PMC: 8894709. DOI: 10.3389/fcimb.2022.810604.
A case of mycetoma-like chromoblastomycosis in Qatar.
Ali G, Goravey W, Taj-Aldeen S, Petkar M, Al-Bozom I, Hadi H IDCases. 2020; 21:e00853.
PMID: 32528848 PMC: 7283144. DOI: 10.1016/j.idcr.2020.e00853.
Coelho R, Brito-Santos F, Figueiredo-Carvalho M, Silva J, Gutierrez-Galhardo M, do Valle A PLoS Negl Trop Dis. 2018; 12(7):e0006675.
PMID: 30048450 PMC: 6080783. DOI: 10.1371/journal.pntd.0006675.
Dong B, Tong Z, Li R, Chen S, Liu W, Liu W PLoS Negl Trop Dis. 2018; 12(2):e0006237.
PMID: 29481557 PMC: 5843349. DOI: 10.1371/journal.pntd.0006237.
Chromoblastomycosis: tissue modifications during itraconazole treatment.
Purim K, Calvo Peretti M, Neto J, Olandoski M An Bras Dermatol. 2017; 92(4):478-483.
PMID: 28954095 PMC: 5595593. DOI: 10.1590/abd1806-4841.20175466.